Coinbase is seeking U.S. regulatory approval to offer perpetual futures tied to individual stocks, a product that could let eligible traders take leveraged long or short positions around the clock. The important word is “seeking”: this is not a launch or an approval. But it is a meaningful attempt to bring one of crypto’s most popular trading formats into a more regulated U.S. market for equities.
Perpetual futures do not expire like normal futures contracts. That makes them convenient for traders, but leverage can turn a modest stock move into a rapid loss. If regulators allow the product, Coinbase could compete for activity now routed to offshore venues and give sophisticated U.S. users a single venue for crypto and stock-linked derivatives. The commercial upside is broader product choice and potentially more regulated market infrastructure. The user downside is familiar: 24/7 trading and leverage leave less time for risk controls when news breaks.
A related development matters for the competitive backdrop. The CFTC has moved to dismiss CME’s lawsuit challenging approval of crypto perpetual futures at Kalshi, arguing CME lacks standing. That does not settle the underlying policy question, but it suggests the fight over who can list perpetual-style products is moving through regulators and courts rather than remaining confined to offshore exchanges.
This is upside for regulated market access, not a signal to chase leverage. It matters most to active derivatives traders, exchanges, brokers and risk teams; long-term holders should watch whether approval brings better hedging tools without mistaking a filing for guaranteed adoption.